Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KX2-361 is a orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 148.00 | |
5 mg | In stock | $ 336.00 | |
10 mg | In stock | $ 497.00 | |
25 mg | In stock | $ 793.00 | |
50 mg | In stock | $ 1,130.00 | |
100 mg | In stock | $ 1,520.00 | |
500 mg | In stock | $ 2,970.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 377.00 |
Description | KX2-361 is a orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma |
Molecular Weight | 405.46 |
Formula | C24H24FN3O2 |
CAS No. | 897016-26-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 8.75 mg/mL (21.58 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KX2-361 897016-26-1 Angiogenesis Cytoskeletal Signaling Others Tyrosine Kinase/Adaptors Src Microtubule Associated KX2361 KX2 361 KX-2-361 inhibitor inhibit